Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis

INTRODUCTION: Next‐generation sequencing (NGS) and digital polymerase chain reaction (PCR) based platforms have been used to detect EGFR mutations in plasma circulating tumor DNA (ctDNA) with high accuracy. Generally, molecular testing is performed after histopathological analysis. However, many pat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Med
Asıl Yazarlar: Deng, Qinfang, Fang, Qiyu, Sun, Hui, Singh, Aditi P., Alexander, Mariam, Li, Shenduo, Cheng, Haiying, Zhou, Songwen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Clinical Cancer Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7064093/
https://ncbi.nlm.nih.gov/pubmed/31991049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2869
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller